Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783681 | 12778368 | 1 | I | 20160816 | 20160918 | 20160926 | 20160926 | EXP | BR-ASTRAZENECA-2016SF00850 | ASTRAZENECA | 12882.00 | DY | M | Y | 0.00000 | 20160926 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783681 | 12778368 | 1 | PS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 12 | G | U | U | 50706 | 2 | G | SOLUTION FOR INJECTION | Q8H | |||
| 127783681 | 12778368 | 2 | SS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 12 | G | U | U | 50706 | 2 | G | SOLUTION FOR INJECTION | Q8H | |||
| 127783681 | 12778368 | 3 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 0 | FILM-COATED TABLET | |||||||||
| 127783681 | 12778368 | 4 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 127783681 | 12778368 | 5 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 6 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 7 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 8 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 9 | C | FENTANIL | FENTANYL | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 10 | C | ISONIAZID. | ISONIAZID | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 11 | C | PYRAZINAMIDE. | PYRAZINAMIDE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 12 | C | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 13 | C | RIFAMPICIN | RIFAMPIN | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 14 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | 0 | ||||||||||||
| 127783681 | 12778368 | 15 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127783681 | 12778368 | 1 | Septic shock |
| 127783681 | 12778368 | 2 | Klebsiella infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127783681 | 12778368 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127783681 | 12778368 | Pathogen resistance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127783681 | 12778368 | 1 | 20160815 | 0 | ||
| 127783681 | 12778368 | 2 | 20160815 | 0 |